{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:00:20Z","timestamp":1787313620200,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFE0207300"],"award-info":[{"award-number":["2018YFE0207300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871302"],"award-info":[{"award-number":["81871302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Beh\u00e7et\u2019s disease (BD), a chronic vascular inflammatory disease, is characterized by the symptoms of ocular lesions, recurrent genital and oral ulcers, skin symptoms and arthritis in addition to neurological, intestinal and vascular involvement. The pathogenesis of BD is poorly understood, and there are no effective laboratory markers for the diagnosis of BD. In addition, BD is presently incurable. Chemokines, a family of small secreted chemotactic cytokines, interact with chemokine receptors and mediate the migration, localization and cellular interactions of inflammatory cells. Several studies have suggested that chemokines and their receptors play an important role in the occurrence and development of BD and that these chemokines along with their receptors can be utilized as biomarkers and therapeutic targets. In the present review, chemokines and chemokine receptors involved in BD and their potential application in diagnosis and therapy have been discussed.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1109147","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T01:36:18Z","timestamp":1674005778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Chemokines and chemokine receptors in Beh\u00e7et\u2019s disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.208","article-title":"Beh\u00e7et syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.55563\/clinexprheumatol\/lnvc9k","article-title":"One year in review 2021: Beh\u00e7et\u2019s syndrome","author":"Hatemi","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/h4dkrs","article-title":"Beh\u00e7et\u2019s syndrome: one year in review 2022","volume":"40","author":"Hatemi","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of behcet\u2019s disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15207","article-title":"Guidelines for the treatment of skin and mucosal lesions in beh\u00e7et\u2019s disease: A secondary publication","volume":"47","author":"Nakamura","year":"2020","journal-title":"J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"Update of the EULAR recommendations for the management of beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8643-2","article-title":"Unmet needs in the pathogenesis and treatment of vasculitides","volume":"54","author":"Muratore","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0323-6","article-title":"Chemokines in rheumatic diseases: pathogenic role and therapeutic implications","volume":"15","author":"Miyabe","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212110","article-title":"CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease","volume":"77","author":"Akiyama","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20102010","article-title":"CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity","volume":"208","author":"Cruz-Orengo","year":"2011","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in beh\u00e7et\u2019s disease: relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","volume":"23","author":"Houman","year":"2004","journal-title":"J Autoimmun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab052","article-title":"Distinct transcriptional profile of blood mononuclear cells in beh\u00e7et\u2019s disease: insights into the central role of neutrophil chemotaxis","volume":"60","author":"Verrou","year":"2021","journal-title":"Rheumatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3109\/08820139.2016.1153652","article-title":"The IL-8 gene polymorphisms in beh\u00e7et\u2019s disease observed in denizli province of Turkey","volume":"45","author":"Atalay","year":"2016","journal-title":"Immunol Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14766","article-title":"Association of single nucleotide polymorphisms in CXCR1, CXCR2 and CXCL5 with beh\u00e7et disease: a study in the denizli province of Turkey","volume":"46","author":"Ar\u0131kan","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.humimm.2009.09.354","article-title":"Monocyte chemoattractant protein-1 -2518 A\/G single nucleotide polymorphism in Chinese han patients with ocular beh\u00e7et\u2019s disease","volume":"71","author":"Hou","year":"2010","journal-title":"Hum Immunol"},{"key":"B17","article-title":"Association of chemokine receptor 5 (CCR5) delta32 mutation with beh\u00e7et\u2019s disease is dependent on gender in Iranian patients","volume":"24","author":"Mojtahedi","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes238","article-title":"CC chemokine receptor 5 polymorphism in Italian patients with behcet\u2019s disease","volume":"51","author":"Atzeni","year":"2012","journal-title":"Rheumatology"},{"key":"B19","article-title":"CC chemokine receptor polymorphism CCR5\u039432 in Portuguese beh\u00e7et\u2019s disease patients","volume":"32","author":"Bettencourt","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2013.847457","article-title":"The chemokine receptor 5 delta32 polymorphism and type 1 diabetes, behcet\u2019s disease, and asthma: a meta-analysis","volume":"43","author":"Song","year":"2014","journal-title":"Immunol Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01085","article-title":"Beh\u00e7et\u2019s syndrome as a model of thrombo-inflammation: The role of neutrophils","volume":"10","author":"Emmi","year":"2019","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214335","article-title":"Critical role of neutrophil extracellular traps (NETs) in patients with behcet\u2019s disease","volume":"78","author":"Le Joncour","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2018.08.010","article-title":"Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in beh\u00e7et\u2019s disease","volume":"92","author":"Safi","year":"2018","journal-title":"J Dermatol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590622","article-title":"Neutrophil extracellular traps promote aberrant macrophages activation in beh\u00e7et\u2019s disease","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.07.017","article-title":"Possible mechanisms of neutrophil activation in beh\u00e7et\u2019s disease","volume":"17","author":"Neves","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199909)42:9<1967::aid-anr24>3.0.co;2-z","article-title":"Th1 polarization of the immune response in beh\u00e7et\u2019s disease: a putative pathogenetic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852297","article-title":"The roles of monocytes and macrophages in beh\u00e7et\u2019s disease with focus on M1 and M2 polarization","volume":"13","author":"Hirahara","year":"2022","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/1547691x.2017.1346008","article-title":"Genetics and immunodysfunction underlying beh\u00e7et\u2019s disease and immunomodulant treatment approaches","volume":"14","author":"Salmaninejad","year":"2017","journal-title":"J Immunotoxicol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.08.016","article-title":"CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation","volume":"37","author":"Groom","year":"2012","journal-title":"Immunity"},{"key":"B30","article-title":"The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with beh\u00e7et\u2019s disease","volume":"31","author":"Yilmaz","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577631","article-title":"Infliximab for reversible dementia in acute onset of neuro-beh\u00e7et\u2019s disease: A case report and cytokine analysis","volume":"357","author":"Imabayashi","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-003-0304-5","article-title":"Elevated serum chemokine levels in beh\u00e7et\u2019s disease with uveitis","volume":"23","author":"Bozkurt","year":"2003","journal-title":"Rheumatol Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000313546","article-title":"Chemokine expression of intraocular lymphocytes in patients with beh\u00e7et uveitis","volume":"45","author":"Kim","year":"2011","journal-title":"Ophthalmic Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.8583","article-title":"Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-beh\u00e7et\u2019s disease","volume":"51","author":"Hirohata","year":"2012","journal-title":"Intern Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-004-0524-3","article-title":"Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with beh\u00e7et\u2019s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis","volume":"26","author":"Erdem","year":"2005","journal-title":"Rheumatol Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21772","article-title":"Serum cytokine levels in beh\u00e7et\u2019s disease","volume":"29","author":"Akkurt","year":"2015","journal-title":"J Clin Lab Anal"},{"key":"B37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.imlet.2016.10.012","article-title":"Longitudinal analysis of serum cytokines in a behcet\u2019s patient during 9 months of IVIG infusions: how does CXCL8 bridge the immune and neuroendocrine systems","volume":"180","author":"Capittini","year":"2016","journal-title":"Immunol Lett"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14720","DOI":"10.1038\/s41598-017-15189-9","article-title":"CXCL10\/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with beh\u00e7et\u2019s disease","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2016.0181","article-title":"Biomarker discovery by modeling beh\u00e7et\u2019s disease with patient-specific human induced pluripotent stem cells","volume":"26","author":"Son","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.03.007","article-title":"CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"216","author":"El-Asrar","year":"2011","journal-title":"Immunobiology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.794800","article-title":"Novel insights into gene signatures and their correlation with immune infiltration of peripheral blood mononuclear cells in behcet\u2019s disease","volume":"12","author":"Zhan","year":"2021","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-003-0668-y","article-title":"Plasma and whole-blood chemokine levels in patients with behcet\u2019s disease","volume":"241","author":"Kaburaki","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-004-0519-0","article-title":"MIP-1alpha, and MCP-1 levels in beh\u00e7et\u2019s disease","volume":"25","author":"Ozer","year":"2005","journal-title":"Rheumatol Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/03009740600905380","article-title":"Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with behcet\u2019s disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD","volume":"35","author":"Dalghous","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/02713680490904331","article-title":"CXCR2 expression on neutrophils is upregulated during the relapsing phase of ocular behcet disease","volume":"30","author":"Qiao","year":"2005","journal-title":"Curr Eye Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/17425255.2020.1711884","article-title":"Clinical significance of chemokine receptor antagonists","volume":"16","author":"Miao","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.immuni.2019.06.026","article-title":"Programming of distinct chemokine-dependent and -independent search strategies for Th1 and Th2 cells optimizes function at inflamed sites","volume":"51","author":"Gaylo-Moynihan","year":"2019","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13102","article-title":"The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced beh\u00e7et\u2019s disease mouse model","volume":"158","author":"Sayeed","year":"2019","journal-title":"Immunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1109147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T01:36:24Z","timestamp":1674005784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1109147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2023.1109147"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1109147","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"article-number":"1109147"}}